AustralianSuper Pty Ltd Makes New $15.74 Million Investment in Aveanna Healthcare Holdings Inc. $AVAH

AustralianSuper Pty Ltd purchased a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,774,837 shares of the company’s stock, valued at approximately $15,743,000. AustralianSuper Pty Ltd owned approximately 0.85% of Aveanna Healthcare at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Federated Hermes Inc. raised its position in Aveanna Healthcare by 226.0% in the 3rd quarter. Federated Hermes Inc. now owns 393,155 shares of the company’s stock valued at $3,487,000 after buying an additional 272,561 shares during the last quarter. Teacher Retirement System of Texas raised its holdings in shares of Aveanna Healthcare by 232.8% in the third quarter. Teacher Retirement System of Texas now owns 224,375 shares of the company’s stock valued at $1,990,000 after purchasing an additional 156,947 shares during the last quarter. Olympiad Research LP lifted its position in shares of Aveanna Healthcare by 7.5% in the third quarter. Olympiad Research LP now owns 31,621 shares of the company’s stock worth $280,000 after purchasing an additional 2,200 shares in the last quarter. State of Alaska Department of Revenue acquired a new position in Aveanna Healthcare during the third quarter worth $106,000. Finally, SG Americas Securities LLC bought a new position in Aveanna Healthcare in the third quarter valued at $153,000. 87.96% of the stock is currently owned by institutional investors.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $8.34 on Friday. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The company has a market capitalization of $1.74 billion, a P/E ratio of 23.17 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.67 and a 12 month high of $10.32. The stock has a 50 day moving average of $8.86 and a 200-day moving average of $8.03.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.08. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $621.94 million during the quarter, compared to the consensus estimate of $578.57 million. As a group, equities research analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on AVAH shares. BMO Capital Markets started coverage on shares of Aveanna Healthcare in a research report on Thursday, November 13th. They set an “outperform” rating and a $11.00 price target on the stock. UBS Group upped their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, January 15th. Truist Financial raised their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research note on Friday, November 7th. William Blair started coverage on Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating on the stock. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $11.06.

Insider Buying and Selling at Aveanna Healthcare

In related news, insider Edwin C. Reisz sold 17,613 shares of the company’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $138,262.05. Following the transaction, the insider owned 1,321,114 shares in the company, valued at approximately $10,370,744.90. This represents a 1.32% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Deborah Stewart sold 11,962 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total transaction of $93,901.70. Following the sale, the chief accounting officer owned 251,676 shares of the company’s stock, valued at $1,975,656.60. This trade represents a 4.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 259,638 shares of company stock worth $2,109,595 in the last ninety days. Insiders own 7.80% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.